127 related articles for article (PubMed ID: 8512572)
1. Autoinduction of platelet derived growth factor (PDGF) A-chain mRNA expression in a human malignant melanoma cell line and growth inhibitory effects of PDGF-A-chain mRNA-specific antisense molecules.
Behl C; Bogdahn U; Winkler J; Apfel R; Brysch W; Schlingensiepen KH
Biochem Biophys Res Commun; 1993 Jun; 193(2):744-51. PubMed ID: 8512572
[TBL] [Abstract][Full Text] [Related]
2. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
Dorai T; Kobayashi H; Holland JF; Ohnuma T
Mol Pharmacol; 1994 Sep; 46(3):437-44. PubMed ID: 7935323
[TBL] [Abstract][Full Text] [Related]
3. Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling.
Matsui T; Sano K; Tsukamoto T; Ito M; Takaishi T; Nakata H; Nakamura H; Chihara K
J Clin Invest; 1993 Sep; 92(3):1153-60. PubMed ID: 8376577
[TBL] [Abstract][Full Text] [Related]
4. Effect of PDGF, IL-1alpha, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea.
Kim WJ; Mohan RR; Mohan RR; Wilson SE
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1364-72. PubMed ID: 10359318
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of tumor-associated alpha 2-macroglobulin and growth factors in human melanoma cell lines.
Lizonová A; Bízik J; Grófóva M; Vaheri A
J Cell Biochem; 1990 Aug; 43(4):315-25. PubMed ID: 1697862
[TBL] [Abstract][Full Text] [Related]
6. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
Schadendorf D; Möller A; Algermissen B; Worm M; Sticherling M; Czarnetzki BM
J Immunol; 1993 Sep; 151(5):2667-75. PubMed ID: 8360485
[TBL] [Abstract][Full Text] [Related]
7. Human keratinocytes are a major source of cutaneous platelet-derived growth factor.
Ansel JC; Tiesman JP; Olerud JE; Krueger JG; Krane JF; Tara DC; Shipley GD; Gilbertson D; Usui ML; Hart CE
J Clin Invest; 1993 Aug; 92(2):671-8. PubMed ID: 8349805
[TBL] [Abstract][Full Text] [Related]
8. Growth factor modulation of melanoma growth stimulatory activity mRNA expression in human malignant melanoma cells correlates with cell growth.
Bordoni R; Thomas G; Richmond A
J Cell Biochem; 1989 Apr; 39(4):421-8. PubMed ID: 2722970
[TBL] [Abstract][Full Text] [Related]
9. IL-1 and transforming growth factor-beta inhibit platelet-derived growth factor-AA binding to osteoblastic cells by reducing platelet-derived growth factor-alpha receptor expression.
Yeh YL; Kang YM; Chaibi MS; Xie JF; Graves DT
J Immunol; 1993 Jun; 150(12):5625-32. PubMed ID: 8515080
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: an immunohistochemical and in situ hybridization study.
Wang J; Coltrera MD; Gown AM
Cancer Res; 1994 Jan; 54(2):560-4. PubMed ID: 7903911
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression.
Hung WC; Huang JS; Chuang LY
Biochem Biophys Res Commun; 1996 Mar; 220(3):719-23. PubMed ID: 8607831
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells.
DiPaola RS; Kuczynski WI; Onodera K; Ratajczak MZ; Hijiya N; Moore J; Gewirtz AM
Cancer Gene Ther; 1997; 4(3):176-82. PubMed ID: 9171936
[TBL] [Abstract][Full Text] [Related]
13. Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo.
Langerak AW; De Laat PA; Van Der Linden-Van Beurden CA; Delahaye M; Van Der Kwast TH; Hoogsteden HC; Benner R; Versnel MA
J Pathol; 1996 Feb; 178(2):151-60. PubMed ID: 8683381
[TBL] [Abstract][Full Text] [Related]
14. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells.
Di Paolo S; Gesualdo L; Ranieri E; Grandaliano G; Schena FP
Am J Pathol; 1996 Dec; 149(6):2095-106. PubMed ID: 8952542
[TBL] [Abstract][Full Text] [Related]
15. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD
J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668
[TBL] [Abstract][Full Text] [Related]
16. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
Dabrow MB; Francesco MR; McBrearty FX; Caradonna S
Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315
[TBL] [Abstract][Full Text] [Related]
17. Characterization of platelet-derived growth factor (PDGF) action on a mouse neuroblastoma cell line, NB41, by introduction of an antisense PDGF beta-receptor RNA.
Funa K; Ahgren A
Cell Growth Differ; 1997 Aug; 8(8):861-9. PubMed ID: 9269895
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
19. Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines.
Gerwin BI; Lechner JF; Reddel RR; Roberts AB; Robbins KC; Gabrielson EW; Harris CC
Cancer Res; 1987 Dec; 47(23):6180-4. PubMed ID: 3479241
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts.
Ylä-Outinen H; Aaltonen V; Björkstrand AS; Hirvonen O; Lakkakorpi J; Vähä-Kreula M; Laato M; Peltonen J
J Invest Dermatol; 1998 Mar; 110(3):232-7. PubMed ID: 9506441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
